Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Scientific Corporation (BSX) vs Xylem, Inc. (XYL) Price & Performance

Boston Scientific CorporationTrade
Xylem, Inc.Trade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Xylem, Inc. — how do they compare? Boston Scientific Corporation trades at $51.75 (market cap $74.52B), while Xylem, Inc. trades at $120.74 (market cap $28.47B). The key difference: Boston Scientific Corporation is far larger — about 2.6× Xylem, Inc.'s market cap, and Xylem, Inc. pays a 1.41% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.

BSXXYL
Market Cap
$74.52B$28.47B
Sector
HealthIndustrials
52-Week High
$108.14$152.95
52-Week Low
$42.63$106.34
Enterprise Value
$86.60B$30.25B
Dividend Yield
1.41%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX

About Xylem, Inc.

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.

Read more on XYL